Below is a link to an article about a study documenting the halting of some drug trials and the possible consequences of this.
Yes, making new therapies may provide benefit to some cancer survivors. But as this article points out, a complete trial will offer more information than just possible benefits- like dosing and possible side effects. David
"The Annals of Oncology report showed that of the 25 trials randomly chosen, 14 had been stopped in the past three years."
"But he warned: "Data on effectiveness and potential side-effects can be missed by stopping a trial early."
He admitted there was no hard evidence of this, but said there was an in-built bias in the system because trials were often only stopped early because the results were positive, when this could just be a "random high".
Post new comment